Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,908 signal articles · 134 in last 24h · 135,581 total before filter · latest 58m ago
134last 24h
1101last 7d
179● bullish (7d)
144● bearish (7d)
209publishers
AllMacro304Earnings358M&A79Regulatory24Product11Analyst16
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Why Is Advantest (TSE:6857) Drawing Investor Attention This Earnings Season?
Simply Wall St.16d agoneutral
Why Is Advantest (TSE:6857) Drawing Investor Attention This Earnings Season?

Advantest (TSE:6857) exceeded market earnings estimates in what is being described as Japan's strongest quarterly reporting season in five years. Chip-related firms including Advantest outpaced expectations, supporting hopes for a broader rally in Japanese equities beyond AI focused stocks. The earnings beat highlighted resilience to higher energy costs and suggested pricing power within key parts of Japan's semiconductor supply chain. For readers looking to build on this theme and find...

Analog Devices Q3 Earnings Call Highlights
MarketBeat16d agoneutral
Analog Devices Q3 Earnings Call Highlights

Analog Devices (NASDAQ:ADI) reported fiscal third-quarter results that exceeded its outlook, with record revenue of $4.02 billion as growth accelerated across its industrial, automotive, communications and consumer markets. CEO and Chair Vincent Roche said the company’s first $4 billion quarter was

Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
Bloomberg16d agobullishVIDEO
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Lowe's (LOW) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks16d agoneutral
Lowe's (LOW) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Lowe's (LOW) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Why Baidu (BIDU) Is Down 14.2% After Weak Q2 Earnings And Faster AI-First Shift
Simply Wall St.16d agoneutral
Why Baidu (BIDU) Is Down 14.2% After Weak Q2 Earnings And Faster AI-First Shift

In the second quarter of 2026, Baidu reported CNY 31,325 million in revenue and CNY 2,319 million in net income, well below the prior year, while also completing a CNY 259 million share buyback covering 2,067,623 shares under its February 2026 program. At the same time, Baidu accelerated its AI-first shift with strong growth in AI cloud and GPU infrastructure, reshaped key board committees ahead of its Hong Kong dual primary listing, and faced weaker online advertising that weighed heavily...

Lowe's Companies Q2 Earnings Call Highlights
MarketBeat16d agoneutral
Lowe's Companies Q2 Earnings Call Highlights

Lowe's Companies (NYSE:LOW) reported second-quarter sales of $26 billion, up 8.3% from a year earlier, as growth in its professional customer, online and home-services businesses helped offset continued pressure on discretionary do-it-yourself spending. Comparable sales increased 0.2% in the quarte

Estée Lauder shares surge on earnings beat, raised margin guidance
Proactive16d agobullish
Estée Lauder shares surge on earnings beat, raised margin guidance

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Target Q2 Earnings Call Highlights
MarketBeat16d agoneutral
Target Q2 Earnings Call Highlights

Target (NYSE:TGT) reported second-quarter sales and profit growth that executives said reflected early traction from the retailer's refreshed strategy, including merchandising changes, store investments, improved inventory availability and continued emphasis on value. Net sales rose 5.3% year over

Estee Lauder Companies Q4 Earnings Call Highlights
MarketBeat16d agoneutral
Estee Lauder Companies Q4 Earnings Call Highlights

Estee Lauder Companies (NYSE:EL) said fiscal 2026 marked a return to growth and a substantial improvement in profitability as the prestige beauty company advanced its Beauty Reimagined strategy and Profit Recovery and Growth Plan. For the full fiscal year, reported sales rose 5% and organic sales i